CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress
Ari Misael Martínez‐Torres,Julio Morán
DOI: https://doi.org/10.1111/cns.70099
2024-11-06
CNS Neuroscience & Therapeutics
Abstract:During excitotoxicity, reactive oxygen species, produced by NADPH‐oxidase 2 (NOX‐2), increases the levels of aquaporin‐4 (AQP4) leading to the rupture of the blood–brain barrier and cerebral edema. This along with oxidative stress contributes to neuronal death. Stimulation of cannabinoid receptor type 1 receptors relieves oxidative stress by a reduction of NOX‐2 activity and thus inhibits AQP4 increase, edema, and brain damage. The endocannabinoid system can be a therapeutic target for limiting brain damage. Background Excitotoxicity is a process in which NADPH oxidase‐2 (NOX‐2) plays a pivotal role in the generation of reactive oxygen species (ROS). Oxidative stress influences the expression of Aquaporin 4 (AQP4), a water channel implicated in blood–brain barrier (BBB) permeability and edema formation. The endocannabinoid system is widely distributed in the brain, particularly through the cannabinoid receptor type 1 (CB1) and type 2 (CB2), which have been shown to have a neuroprotective function in brain injury. Given the significant involvement of NOX‐2 in ROS production during excitotoxicity, our research aims to assess the participation of NOX‐2 in the neuroprotective effect of the cannabinoid receptor agonist WIN55,212‐2 against glutamate‐induced excitotoxicity damage in the striatum using in vivo model. Methods Wild‐type mice (C57BL/6) and NOX‐2 KO (gp91Cybbtm1Din/J) were stereotactically injected in the striatum with monosodium glutamate or vehicle. Subsequently, a group of mice was administered an intraperitoneal dose of WIN55,212‐2, AM251, or AM251/WIN55,212‐2 following the intracerebral injection. Motor activity was assessed, and the lesion was examined through histological sections stained with cresyl violet. Additionally, brain water content and Evans blue assay were conducted. The activity of NOX was quantified, and the protein expression of CB1, gp91phox, AQP4, Iba‐1, TNF‐α, and NF‐κB was analyzed using Western blot. Furthermore, ROS formation was measured through the DHE assay. Results The activation of the endocannabinoid receptors demonstrated a neuroprotective response during excitotoxicity, meditated by NOX‐2. The reduction in ROS production led to a decrease in neuroinflammation, and AQP4 expression, resulting in reduced edema formation, and BBB permeability. Conclusions During excitotoxic damage, WIN55,212‐2 inhibits NOX‐2‐induced ROS production, reducing brain injury.
pharmacology & pharmacy,neurosciences